Ledger.Open graph →
SEC Form D · Amendment · filed October 9, 2019

SEngine Precision Medicine, Inc

Offering
$13.6M
Sold
$8.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Christopher Kemp · Seatttle, WAExec · PromoterElliott Burkland · Seattle, WADirectorCarla Grandori · Seattle, WAExec · Director · PromoterTom Neary · Seattle, WAExecJesse Ferrer · Seattle, WADirectorUlrich Mueller · Seattle, WAExecTim Kiefer · Munsbach, LuxembourgDirectorAshoat Tevosyan · New York, NYExecDonatien-Xavier Martin · Munsbach, LuxembourgExec · PromoterJerome Misso · Munsbach, LuxembourgDirectorAndrew S. Gazdecki · San Mateo, CAExec · Director · PromoterLee Hartwell · Seattle, WADirectorRavikiran Thummalapenta · CENTERVILLE, VADirectorTom B. Orradre · Newport Beach, CAExec · PromoterThomas D. Kenneally · Schenectady, NYDirectorTobias Peggs · Brooklyn, NYExecGeorge Matelich · Brooklyn, NYExec · Director · PromoterTom Neary · Seattle, WAExecLee Hartwell · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗